Although the dynamic interplay of these mediators of OTX2 repression during medulloblastoma initiation are currently unknown, an improved understanding of the cellular origins of this tumor and the developmental regulation of OTX2 therein should clarify these remaining questions regarding the molecular pathogenesis of OTX2-driven medulloblastoma. The gene discussed is OTX2; the disease is neoplasm.